Ovarian cancer screening: Where are we at now?
O&G
•
27m
Screening for ovarian cancer has been attempted since the late 1980's. Most studies have involved the use of clinical examination CA 125 estimation and serial ultrasound scans. Large trials where conducted in the United Kingdom and thus far there has been no statistical evidence that these have reduced the incidence or death rate from ovarian cancer.
Even high risk patients with known mutations of BRCA 1 or 2 have not been found to benefit from surveillance ultrasound scans.
?There are a number of world health organisation criteria for screening tests which are unable to be satisfied for an effective screening test to be produced. Current research is identifying pre-invasive lesions which may be able to be used in the future and a discussion about imaging will be undertaken.
Up Next in O&G
-
From IOTA to O-RADs system: Tools to ...
Not Found
-
Combined screening for Down syndrome ...
Combined screening for Down Syndrome in the NIPT era. Maternal age screening began in the 1970's with amniocentesis and has transitioned to NIPT that was commercially viable. Ultrasound remains the current gold standard for screening with biochemistry results.
-
Differential diagnosis of a thickened...
In this talk we will discuss three common endometrial pathologies, namely, endometrial polyps, endometrial hyperplasia and endometrial carcinoma. These can all cause abnormal uterine bleeding and often present as a thickened endometrium on ultrasound, making their diagnosis challenging at times.
...
